PMC:7534795 / 22670-22855 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T186","span":{"begin":54,"end":63},"obj":"Disease"}],"attributes":[{"id":"A186","pred":"mondo_id","subj":"T186","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"• Prospective RCT\n• 18 to 75 years of age with severe infection\n• Primary outcome of time to clinical improvement\n• N = 20 ruxolitinib + standard care\n• N = 21 placebo + standard care"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T39273","span":{"begin":20,"end":22},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":"• Prospective RCT\n• 18 to 75 years of age with severe infection\n• Primary outcome of time to clinical improvement\n• N = 20 ruxolitinib + standard care\n• N = 21 placebo + standard care"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T165","span":{"begin":124,"end":135},"obj":"Chemical"}],"attributes":[{"id":"A165","pred":"chebi_id","subj":"T165","obj":"http://purl.obolibrary.org/obo/CHEBI_66919"}],"text":"• Prospective RCT\n• 18 to 75 years of age with severe infection\n• Primary outcome of time to clinical improvement\n• N = 20 ruxolitinib + standard care\n• N = 21 placebo + standard care"}

{"project":"LitCovid-sentences","denotations":[{"id":"T158","span":{"begin":18,"end":63},"obj":"Sentence"},{"id":"T159","span":{"begin":64,"end":113},"obj":"Sentence"},{"id":"T160","span":{"begin":114,"end":151},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"• Prospective RCT\n• 18 to 75 years of age with severe infection\n• Primary outcome of time to clinical improvement\n• N = 20 ruxolitinib + standard care\n• N = 21 placebo + standard care"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T93","span":{"begin":47,"end":63},"obj":"Phenotype"}],"attributes":[{"id":"A93","pred":"hp_id","subj":"T93","obj":"http://purl.obolibrary.org/obo/HP_0032169"}],"text":"• Prospective RCT\n• 18 to 75 years of age with severe infection\n• Primary outcome of time to clinical improvement\n• N = 20 ruxolitinib + standard care\n• N = 21 placebo + standard care"}